RT Journal Article
SR Electronic
T1 Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006665
DO 10.1136/jitc-2023-006665
VO 11
IS 8
A1 Carpenter, Elizabeth Lee
A1 Van Decar, Spencer
A1 Adams, Alexandra M
A1 O’Shea, Anne E
A1 McCarthy, Patrick
A1 Chick, Robert Connor
A1 Clifton, Guy Travis
A1 Vreeland, Timothy
A1 Valdera, Franklin A
A1 Tiwari, Ankur
A1 Hale, Diane
A1 Kemp Bohan, Phillip
A1 Hickerson, Annelies
A1 Smolinsky, Todd
A1 Thomas, Katryna
A1 Cindass, Jessica
A1 Hyngstrom, John
A1 Berger, Adam C
A1 Jakub, James
A1 Sussman, Jeffrey J
A1 Shaheen, Montaser F
A1 Yu, Xianzhong
A1 Wagner, Thomas E
A1 Faries, Mark
A1 Peoples, George E
YR 2023
UL http://jitc.bmj.com/content/11/8/e006665.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.